These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16153395

  • 1. Individual and joint association of alpha1A-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects.
    Jiang S, Mao G, Zhang S, Hong X, Tang G, Li Z, Liu X, Zhang Y, Wang B, Xu X, Wang X.
    Clin Pharmacol Ther; 2005 Sep; 78(3):239-48. PubMed ID: 16153395
    [Abstract] [Full Text] [Related]

  • 2. Interactive effect of angiotensin II type 1 receptor (AGT1R) polymorphisms and plasma irbesartan concentration on antihypertensive therapeutic responses to irbesartan.
    Jiang S, Hsu YH, Venners SA, Zhang Y, Xing H, Wang X, Xu X.
    J Hypertens; 2011 May; 29(5):890-5. PubMed ID: 21346624
    [Abstract] [Full Text] [Related]

  • 3. Association between human atrial natriuretic peptide Val7Met polymorphism and baseline blood pressure, plasma trough irbesartan concentrations, and the antihypertensive efficacy of irbesartan in rural Chinese patients with essential hypertension.
    Zhang S, Mao G, Zhang Y, Tang G, Wen Y, Hong X, Jiang S, Yu Y, Xu X.
    Clin Ther; 2005 Nov; 27(11):1774-84. PubMed ID: 16368448
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CYP2C9 Ile359Leu polymorphism, plasma irbesartan concentration and acute blood pressure reductions in response to irbesartan treatment in Chinese hypertensive patients.
    Chen G, Jiang S, Mao G, Zhang S, Hong X, Tang G, Li Z, Liu X, Zhang Y, Xing H, Wang B, Yu Y, Xu X.
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(1):19-24. PubMed ID: 16541193
    [Abstract] [Full Text] [Related]

  • 6. The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.
    Kurland L, Hallberg P, Melhus H, Liljedahl U, Hashemi N, Syvänen AC, Lind L, Kahan T.
    Am J Hypertens; 2008 Jul; 21(7):836-9. PubMed ID: 18464745
    [Abstract] [Full Text] [Related]

  • 7. Association of cigarette smoking with steady-state plasma concentration of irbesartan in male Chinese with hypertension.
    Zhang S, Liu P, Jiang S, Hong X, Xing H, Xu X.
    Methods Find Exp Clin Pharmacol; 2005 Apr; 27(3):173-8. PubMed ID: 15834449
    [Abstract] [Full Text] [Related]

  • 8. Arg347Cys polymorphism of alpha1A-adrenoceptor gene is associated with blood pressure response to nifedipine GITS in Chinese hypertensive patients.
    Zhang Y, Hong X, Liu H, Huo Y, Xu X.
    J Hum Genet; 2009 Jun; 54(6):360-4. PubMed ID: 19444285
    [Abstract] [Full Text] [Related]

  • 9. Effects of protein coding polymorphisms in the kallikrein 1 gene on baseline blood pressure and antihypertensive response to irbesartan in Chinese hypertensive patients.
    Jiang S, Hsu YH, Venners SA, Zhang Y, Xing H, Wang X, Xu X.
    J Hum Hypertens; 2011 May; 25(5):327-33. PubMed ID: 20613781
    [Abstract] [Full Text] [Related]

  • 10. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G, Delonca J, Moulin C, Giacomino A, Postel-Vinay N, Asmar R, COmparative Study of Efficacy of Irbesartan/HCTZ with Valsartan/HCTZ Using Home Blood Pressure Monitoring in the TreAtment of Mild-to-Moderate Hypertension (COSIMA) Investigators.
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of irbesartan in hypertensive children and adolescents.
    Sakarcan A, Tenney F, Wilson JT, Stewart JJ, Adcock KG, Wells TG, Vachharajani NN, Hadjilambris OW, Slugg P, Ford NF, Marino MR.
    J Clin Pharmacol; 2001 Jul; 41(7):742-9. PubMed ID: 11452706
    [Abstract] [Full Text] [Related]

  • 12. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
    Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman P, Nyström F, Hägg A, Lind L.
    Am J Hypertens; 2002 May; 15(5):389-93. PubMed ID: 12022239
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of the antihypertensive activity of fosinopril and irbesartan].
    Angulo E, Robles NR, Grois J, Barquero A, Pérez Miranda M.
    An Med Interna; 2002 Nov; 19(11):571-5. PubMed ID: 12522893
    [Abstract] [Full Text] [Related]

  • 14. Renin-angiotensin-aldosterone system gene polymorphisms and antihypertensive response to irbesartan in Chinese hypertensives.
    Liu H, Zhang S, Jiang S, Mao G, Hong X, Yu Y, Zhang Y, Tang G, Xing H, Xu X.
    Methods Find Exp Clin Pharmacol; 2008 May; 30(4):307-12. PubMed ID: 18773126
    [Abstract] [Full Text] [Related]

  • 15. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.
    Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP.
    Circulation; 2005 Mar 01; 111(8):1012-8. PubMed ID: 15723979
    [Abstract] [Full Text] [Related]

  • 16. BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan.
    Schrader J, Bramlage P, Lüders S, Thoenes M, Schirmer A, Paar DW.
    Clin Drug Investig; 2007 Mar 01; 27(11):783-96. PubMed ID: 17914897
    [Abstract] [Full Text] [Related]

  • 17. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov 01; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 18. Comparison of monotherapy with irbesartan 150 mg or amlodipine 5 mg for treatment of mild-to-moderate hypertension.
    Neutel JM, Germino FW, Smith D.
    J Renin Angiotensin Aldosterone Syst; 2005 Sep 01; 6(2):84-9. PubMed ID: 16470487
    [Abstract] [Full Text] [Related]

  • 19. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G, Cicero AF, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Fassi R, Fogari R.
    Clin Ther; 2007 Apr 01; 29(4):602-10. PubMed ID: 17617283
    [Abstract] [Full Text] [Related]

  • 20. Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31,793 patients.
    Strutz F, Bramlage P, Paar WD.
    Curr Med Res Opin; 2005 Sep 01; 21(9):1433-40. PubMed ID: 16197662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.